University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Laura Blackburn.

Abstract not available

This talk is part of the Cambridge Oncology Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Wright Lecture Series Communications Research Group Seminar 'Making All Things New'? Evangelii Gaudium and Ecumenical Mission

Other talks

The frequency of ‘America’ in America Bayesian deep learning Faster C++ Replication or exploration? Sequential design for stochastic simulation experiments A transmissible RNA pathway in honeybees Refugees and Migration Immigration and Freedom Symplectic topology of K3 surfaces via mirror symmetry Real Time Tomography X-Ray Imaging System - Geometry Calibration by Optimisation
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity